English
English
Finished Formulations
Temozolomide; Arsenic Trioxide; Lenalidomide; Docetaxel; Paclitaxel; Filgrastim (Recombinant Human Granulocyte Colony-Stimulating Factor, rh-G-CSF); Recombinant Human Interleukin-11 (rh-IL-11); Recombinant Human Interleukin-2 (125Ala IL-2); Thymopentin; Vinorelbine Bitartrate; Hydroxyl-camptothecine; Nimustine Hydrochloride; Asparaginase; PEG L-Asparaginase; Calcium Foliate; Recombinant Human Basic Fibroblast Growth Factor (rh-bFGF); Liraglutide; Insulin Aspart 30; Insulin Aspart 50; Insulin Aspart; Recombinant Human Follitropin(rh-FSH); Ciclosporin; Mycophenolate Mofetil Dispersible; Ornidazole; Voriconazole; Adefovir Dipivoxil; Levofloxacin Hydrochloride; Azithromycin; Ribavirin; Tenofovir Disoproxil Fumarate; Valacylovir Hydrochloride; Lysozyme; Stavudine; Tropisetron Hydrochloride; Granisetron Hydrochloride; Omeprazole; Ademetionine 1,4-Butanedisulfonate; Glutathione; Rivaroxaban; Enoxaparin Sodium; Coenzyme Complex; Ginkgo Biloba Extract; Simvastatin; Telmisartan; Naftopidil; Nicergoline; Zaleplon; Cytidine Disodium Triphosphate; Febuxostat; Risedronate Sodium; Loratadine Dispersible; Somatostatin; Octreotide Acetate; Calcitonin (Salmon); Paracetamol and Tramadol Hydrochloride; Etodolac
Active Pharmaceutical Ingredients (API)
鍙岄弓鑽笟(002038)绯婚閮界涓€瀹剁櫥闄嗘繁浜ゆ墍鐨勯珮鏂版妧鏈紒涓氾紝1994骞存垚绔嬩互鏉ュ叕鍙稿嚟鍊熸妧鏈紭鍔垮拰涓嶆柇鍒涙柊锛屽凡鐮旂┒寮€鍙戝苟鎶曟斁甯傚満鍏锋湁鑷富鐭ヨ瘑浜ф潈鐨?涓浗瀹朵竴绫绘柊鑽湪鍐呯殑70浣欎釜鍝佺锛岃幏鍥藉绉戞妧杩涙浜岀瓑濂栦竴椤癸紝鍖椾含甯傜鎶€杩涙涓€绛夊銆佷簩绛夊銆佷笁绛夊涔濋」銆侟/span>
鍏虫敞鎴戜滑
Copyright 漏 2005-2024 www.slpharm.com.cn All rights reserved 鐗堟潈鎵€鏈夊寳浜弻楣嵂涓氳偂浠芥湁闄愬叕鍙
浜掕仈缃戣嵂鍝佷俊鎭湇鍔¤祫鏍艰瘉涔?锛堜含锛?闈炵粡钀ユ€?2021-0105
